Arava
$ 56,00 – $ 595,00Price range: $ 56,00 through $ 595,00
Arcoxia
$ 42,00 – $ 271,00Price range: $ 42,00 through $ 271,00
Arcalion
$ 25,00 – $ 50,00Price range: $ 25,00 through $ 50,00
Arcalion is a specialized supplement designed to effectively combat symptoms of physical and mental fatigue. It contains Sulbutiamine, a unique derivative of Vitamin B1 that crosses the blood-brain barrier to support cognitive function and alertness. This medication is primarily indicated for the treatment of asthenia, helping to alleviate persistent feelings of weakness and lethargy. By enhancing energy levels, it assists in restoring vitality during periods of intense stress or recovery. Arcalion provides a targeted approach to improving concentration and overall endurance for those experiencing temporary exhaustion.
Active substance: Sulbutiamine
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Arcalion belongs to a class of synthetic thiamine derivatives engineered to cross the blood-brain barrier with greater efficiency than standard water-soluble thiamine (Vitamin B1). In clinical contexts outside the United States, this compound is prescribed to manage symptoms of functional asthenia and physical or intellectual fatigue. In the United States, any supply or administration is handled in accordance with applicable federal and state regulations.
Understanding the metabolic characteristics, physiological actions, and proper administration guidelines of Arcalion ensures safe use and helps prevent potential adverse events. Patients should always consult a licensed healthcare professional before initiating therapy with synthetic neurotropic agents.
Key Information Overview
| Drug name | Arcalion |
| Active ingredient (INN) | Sulbutiamine |
| Therapeutic class | Central nervous system agent / Synthetic thiamine derivative |
| Dosage form | Coated oral tablet (typically 200 mg) |
| Route of administration | Oral |
| Primary purpose | Symptomatic management of functional asthenia |
| Prescription status | Dispensed in accordance with applicable federal and state regulations |
Detailed Clinical and Usage Profile
How the drug works
The active compound in Arcalion, sulbutiamine, is a lipophilic dimer composed of two modified thiamine molecules linked by a disulfide bond. Because of its lipophilic structure, sulbutiamine diffuses across the blood-brain barrier more rapidly than unsubstituted thiamine, resulting in increased concentrations of thiamine phosphate esters in cerebral tissues. Mechanistically, the drug modulates central neurotransmission, particularly within cholinergic pathways in the hippocampus and dopaminergic receptors in the prefrontal cortex. It also influences glutamatergic signaling, which supports neuronal energy metabolism and synaptic plasticity. By enhancing mitochondrial activity within neurons, the medication helps reduce symptoms of persistent fatigue associated with central nervous system exhaustion.
Main uses
Arcalion is primarily indicated for the symptomatic treatment of functional asthenia, a condition characterized by persistent physical exhaustion, cognitive fatigue, and low energy levels not directly attributable to organic disease. It is utilized in cases of post-infectious fatigue, asthenia associated with prolonged physical overexertion, and functional mood-related lethargy. Clinical evaluations focus on relieving muscle fatigue, slowing cognitive decline during fatigue episodes, and restoring daily operational stamina. It is important to note that Arcalion is intended for short-term functional management rather than chronic therapeutic replacement for underlying organic, neurological, or psychiatric conditions.
First days of treatment: When initiating therapy, patients typically do not experience immediate acute stimulant sensations. Instead, therapeutic effects manifest gradually over several days as tissue thiamine derivative levels stabilize. Early signs of efficacy often manifest as a slight decrease in morning lethargy and improved mental endurance during prolonged mental tasks. Initial mild restlessness or sleep alterations can occur if the medication is ingested late in the day.
Dosing schedule
The standard adult dosage of Arcalion typically ranges from 400 mg to 800 mg daily, taken in divided doses. Most clinical protocols recommend administering 200 mg to 400 mg with breakfast and an additional dose with lunch. Tablets should be swallowed whole with a full glass of water. Because the drug exhibits mild wakefulness-promoting activity, doses are generally restricted to the morning and early afternoon to prevent sleep disturbances. The total duration of treatment is usually limited to 2 to 4 weeks, depending on individual clinical response and physician recommendation.
If you skip a dose: If a scheduled dose is missed, it should be taken as soon as remembered, provided it is still early in the day. If it is already late afternoon or evening, the missed dose should be skipped entirely, and the normal dosing schedule resumed the following morning. Patients should never double the dose to compensate for a missed tablet, as this increases the risk of agitation and insomnia.
What happens in the body: Following oral administration, sulbutiamine is rapidly absorbed from the gastrointestinal tract. Plasma concentrations reach peak levels within approximately 1 to 2 hours post-ingestion. Once absorbed, the molecule is cleaved into thiamine derivatives and metabolic intermediates that readily penetrate neural membranes. The elimination half-life of sulbutiamine and its primary metabolites is estimated at approximately 5 hours. Excretion occurs predominantly via the kidneys in the form of urinary metabolites.
Adverse reactions
While Arcalion is generally well tolerated, adverse effects may occur in a subset of individuals. Mild psychiatric and neurological reactions include insomnia, agitation, headache, tremor, and mild irritability. Gastrointestinal disturbances, such as nausea, epigastric discomfort, abdominal cramps, and diarrhea, have also been documented. Cutaneous hypersensitivity reactions, including maculopapular rash, pruritus, and localized urticaria, occur infrequently. Elderly individuals or patients sensitive to central nervous system agents may exhibit heightened susceptibility to nocturnal wakefulness and anxiety symptoms.
What to avoid while taking it: Co-administration of Arcalion with alcohol is not recommended, as ethanol can impair thiamine absorption and exacerbate central nervous system irritability. Caution is advised when consuming beverages high in caffeine, such as coffee or energy drinks, because additive stimulant effects may trigger tachycardia, palpitations, or heightened anxiety. Fatty meals taken concurrently with the medication do not significantly alter overall systemic absorption, but taking doses with meals helps minimize potential gastric discomfort.
Compatibility with other medicines: Concurrent use of Arcalion with other central nervous system stimulants or monoamine oxidase inhibitors (MAOIs) requires strict medical supervision due to the risk of exaggerated psychomotor activation. Diuretics, particularly loop diuretics such as furosemide, may accelerate renal thiamine excretion and potentially diminish the therapeutic efficacy of sulbutiamine. Patients taking antihypertensive agents or drugs that prolong the QT interval should discuss potential interactions with their prescribing provider.
Important precautions: Arcalion should be used with caution in patients with a history of severe psychiatric conditions, including bipolar disorder or major anxiety disorders, as central activation may exacerbate mood instability. Safety and efficacy have not been established in pediatric populations or during pregnancy and lactation; therefore, use in these groups is generally avoided unless explicitly directed by a healthcare professional. Individuals with severe renal impairment may require dosage adjustments due to reduced metabolic clearance.
Storage and expiration: Store Arcalion at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), away from excess moisture, direct heat, and sunlight. Keep tablets in their original blister packaging until immediately prior to administration. Ensure the container is stored safely out of the reach and sight of children and domestic pets. Do not use the medication beyond the expiration date stamped on the packaging.
Common questions
How long does Arcalion usually take to show noticeable effects?
Therapeutic responses to Arcalion are typically observed within 3 to 7 days of continuous daily use. Unlike short-acting central nervous system stimulants, sulbutiamine relies on progressive accumulation within neuronal tissues to optimize cellular metabolic processes, so immediate acute onset should not be expected.
Is Arcalion considered a central nervous system stimulant?
Arcalion is classified as a neurotropic agent and thiamine derivative rather than a classic amphetamine-like stimulant. Although it enhances wakefulness and reduces functional fatigue by modulating central neurotransmission, it acts primarily by facilitating neuronal energy metabolism rather than direct sympathomimetic activation.
What should be done if a dose of Arcalion is taken too late in the day?
Taking Arcalion late in the afternoon or evening may lead to onset insomnia or nocturnal restlessness. If a dose is inadvertently taken late, practicing sleep hygiene measures and avoiding additional caffeine can help mitigate potential sleep disruption. Subsequent doses should be strictly confined to morning and midday hours.
Can Arcalion cause dependence or tolerance over extended periods?
Clinical evidence regarding physical dependence on sulbutiamine is minimal; however, tolerance to its psychomotor invigorating effects may develop with prolonged, uninterrupted usage. For this reason, treatment courses are generally limited to short periods of 2 to 4 weeks under appropriate clinical supervision.
Should treatment with Arcalion be tapered off gradually?
In most cases, Arcalion can be discontinued without complex tapering protocols, as abrupt cessation does not typically induce severe withdrawal syndromes. However, patients who have completed a full therapeutic course should follow specific discontinuation guidance provided by their managing physician.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
200 mg |
|---|---|
| Package |
30 tabs ,60 tabs ,90 tabs |
| Ενεργός Ουσία |
Related products
Amalaki
$ 42,00 – $ 72,00Price range: $ 42,00 through $ 72,00
Active substance: Amalaki (Emblica officinalis) Extract
More Details
This product has multiple variants. The options may be chosen on the product page
Beclamethasone
$ 60,00 – $ 205,00Price range: $ 60,00 through $ 205,00
Active substance: Beclomethasone Dipropionate
More Details
This product has multiple variants. The options may be chosen on the product page
Betadine
$ 7,00 – $ 12,00Price range: $ 7,00 through $ 12,00
Active substance: Povidone Iodine
More Details
This product has multiple variants. The options may be chosen on the product page
Ciprodex Ophthalmic Solution
$ 63,00 – $ 95,00Price range: $ 63,00 through $ 95,00
Active substance: Ciprofloxacin, Dexamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Didronel
$ 57,00 – $ 136,00Price range: $ 57,00 through $ 136,00
Active substance: Etidronate
More Details
This product has multiple variants. The options may be chosen on the product page
Ethionamide
$ 49,00 – $ 172,00Price range: $ 49,00 through $ 172,00
Active substance: Ethionamide
More Details
This product has multiple variants. The options may be chosen on the product page
Eurax Lotion
$ 3,00 – $ 15,00Price range: $ 3,00 through $ 15,00
Active substance: Crotamiton
More Details
This product has multiple variants. The options may be chosen on the product page
Limcee
$ 21,00 – $ 39,00Price range: $ 21,00 through $ 39,00
Active substance: Ascorbic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
